Acrivon Therapeutics, Inc. (NASDAQ:ACRV) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Peter Kolchinsky Other companies: Freenome, Inc. (Director · Since at least Jul 20, 2026); Parabilis Medicines, Inc. (Director · Since at least Jun 9, 2026); Hemab Therapeutics Holdings, Inc. (Director · Since at least Apr 30, 2026); SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Evommune, Inc. (Director · Since at least Nov 5, 2025); Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Septerna, Inc. (Director · Since at least Oct 24, 2024); Bicara Therapeutics Inc. (Director · Since at least Sep 12, 2024); Artiva Biotherapeutics, Inc. (Director · Since at least Jul 18, 2024); Cidara Therapeutics Inc (Director · Since at least Apr 24, 2024); LENZ Therapeutics, Inc. (Director · Since at least Mar 21, 2024); Mineralys Therapeutics, Inc. (Director · Since at least Feb 9, 2023); ARS Pharmaceuticals, Inc. (Director · Since at least Nov 8, 2022); PepGen Inc. (Director · Since at least May 5, 2022); Nkarta, Inc. (Director · Since at least Feb 14, 2022); Tyra Biosciences, Inc. (Director · Since at least Sep 14, 2021); Climb Bio, Inc. (Director · Since at least Aug 9, 2021); Acumen Pharmaceuticals, Inc. (Director · Since at least Jun 30, 2021); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); Vor Biopharma Inc. (Director · Since at least Feb 4, 2021); 89bio Inc (Director · Since at least Nov 8, 2019); Wave Life Sciences Ltd. (Director · Since at least Aug 14, 2015); Black Diamond Therapeutics, Inc. (Director · Jul 5, 2023 – Jul 5, 2023 · Past); Iteos Therapeutics Inc (Director · Jun 9, 2022 – Jun 9, 2022 · Past); Icosavax Inc (Director · Jul 28, 2021 – Feb 19, 2024 · Past); Cytek Biosciences, Inc. (Director · Jul 22, 2021 – Mar 14, 2022 · Past); Jade Biosciences, Inc. (Director · Jun 29, 2021 – Jun 17, 2024 · Past); Werewolf Therapeutics, Inc. (Director · Apr 29, 2021 – May 12, 2025 · Past); Research Alliance Corp II (Chief Executive Officer, Director · Mar 17, 2021 – Mar 17, 2021 · Past); Orchard Therapeutics PLC (Director · Feb 9, 2021 – Feb 9, 2021 · Past); Solid Biosciences Inc. (Director · Dec 10, 2020 – Jan 11, 2024 · Past); POINT Biopharma Global Inc (Chief Executive Officer, Director · Jul 7, 2020 – Jun 29, 2021 · Past); Forma Therapeutics Holdings Inc (Director · Jun 18, 2020 – Jun 8, 2022 · Past); Satsuma Pharmaceuticals Inc (Director · Sep 12, 2019 – Jun 3, 2022 · Past); Synthorx Inc (Director · Dec 6, 2018 – Jan 23, 2020 · Past); Kala Bio, Inc. (Director · Oct 3, 2018 – Mar 13, 2020 · Past); Eidos Therapeutics Inc (Director · Jun 19, 2018 – Jun 19, 2018 · Past); KalVista Pharmaceuticals, Inc. (Director · Oct 12, 2017 – Oct 12, 2017 · Past); Ra Pharmaceuticals Inc (Director · Jun 20, 2017 – Apr 2, 2020 · Past); Dicerna Pharmaceuticals Inc (Director · Jan 29, 2014 – Nov 27, 2019 · Past) | Director · Since at least Nov 9, 2022 |
| Rajeev M Shah Other companies: Freenome, Inc. (Director · Since at least Jul 20, 2026); Parabilis Medicines, Inc. (Director · Since at least Jun 9, 2026); Hemab Therapeutics Holdings, Inc. (Director · Since at least Apr 30, 2026); SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Evommune, Inc. (Director · Since at least Nov 5, 2025); Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Septerna, Inc. (Director · Since at least Oct 24, 2024); Bicara Therapeutics Inc. (Director · Since at least Sep 12, 2024); Artiva Biotherapeutics, Inc. (Director · Since at least Jul 18, 2024); Cidara Therapeutics Inc (Director · Since at least Apr 24, 2024); LENZ Therapeutics, Inc. (Director · Since at least Mar 21, 2024); Mineralys Therapeutics, Inc. (Director · Since at least Feb 9, 2023); ARS Pharmaceuticals, Inc. (Director · Since at least Nov 8, 2022); PepGen Inc. (Director · Since at least May 5, 2022); Nkarta, Inc. (Director · Since at least Feb 14, 2022); Tyra Biosciences, Inc. (Director · Since at least Sep 14, 2021); Wave Life Sciences Ltd. (Director · Since at least Aug 16, 2021); Climb Bio, Inc. (Director · Since at least Aug 9, 2021); Acumen Pharmaceuticals, Inc. (Director · Since at least Jun 30, 2021); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); Vor Biopharma Inc. (Director · Since at least Feb 4, 2021); 89bio Inc (Director · Since at least Nov 8, 2019); Iteos Therapeutics Inc (Director · Jun 9, 2022 – Jun 9, 2022 · Past); Forma Therapeutics Holdings Inc (Director · Jun 8, 2022 – Jun 8, 2022 · Past); Icosavax Inc (Director · Jul 28, 2021 – Feb 19, 2024 · Past); Cytek Biosciences, Inc. (Director · Jul 22, 2021 – Mar 14, 2022 · Past); Jade Biosciences, Inc. (Director · Jun 29, 2021 – Jun 17, 2024 · Past); POINT Biopharma Global Inc (Director · Jun 23, 2021 – Jun 29, 2021 · Past); Werewolf Therapeutics, Inc. (Director · Apr 29, 2021 – May 12, 2025 · Past); Orchard Therapeutics PLC (Director · Feb 9, 2021 – Feb 9, 2021 · Past); Black Diamond Therapeutics, Inc. (Director · Jan 29, 2020 – Jul 5, 2023 · Past); Satsuma Pharmaceuticals Inc (Director · Sep 12, 2019 – Jun 6, 2023 · Past); Eidos Therapeutics Inc (Director · Jun 19, 2018 – May 27, 2020 · Past); Solid Biosciences Inc. (Director · Jan 25, 2018 – Jan 11, 2024 · Past); Kala Bio, Inc. (Director · Jul 19, 2017 – Jun 17, 2021 · Past); KalVista Pharmaceuticals, Inc. (Director · Nov 21, 2016 – Oct 12, 2017 · Past); Ra Pharmaceuticals Inc (Director · Oct 25, 2016 – Apr 2, 2020 · Past) | Director · Since at least Nov 9, 2022 |
| Derek DiRocco Other companies: Evommune, Inc. (Board Member · Since at least Nov 5, 2025); Mineralys Therapeutics, Inc. (Board Member · Since at least Feb 9, 2023); 89bio Inc (Director · Since at least Nov 8, 2019); Werewolf Therapeutics, Inc. (Director · Apr 29, 2021 – May 24, 2024 · Past); Iteos Therapeutics Inc (Director · Jul 23, 2020 – Jun 13, 2023 · Past) | Director · Since at least Nov 9, 2022 |
| Ivana Magovčević-Liebisch Other companies: Quanterix Corporation (President · Since at least Oct 2, 2024); Vigil Neuroscience Inc (President and CEO, Director · Since at least Jan 6, 2022); Absci Corporation (Director · Jul 21, 2021 – Jun 8, 2022 · Past); Spyre Therapeutics, Inc. (Director · Mar 22, 2018 – Jun 22, 2023 · Past); Dyax Corp (EVP; Chief Operating Officer · Jul 3, 2006 – Mar 29, 2013 · Past) | Director · Since at least Feb 8, 2024 |
| Charles Baum Other companies: PMV Pharmaceuticals, Inc. (Director · Since at least Apr 1, 2021); Poseida Therapeutics Inc (Director · May 16, 2022 – Jan 8, 2025 · Past); Tango Therapeutics, Inc. (Director · Sep 2, 2020 – Sep 2, 2020 · Past); Immunomedics Inc (Director · Feb 23, 2019 – Oct 23, 2020 · Past) | Director · Since at least Jun 22, 2023 |
| Michael Tomsicek Other companies: Milestone Pharmaceuticals Inc. (Independent Non-Executive Director · Since at least May 8, 2019); CRISPR Therapeutics AG (Chief Financial Officer · Nov 13, 2017 – Aug 6, 2021 · Past); ABIOMED Inc (Vice President, CFO · Jul 15, 2015 – Jul 15, 2017 · Past); Cubist Pharmaceuticals Inc (SVP & Chief Financial Officer · Mar 4, 2013 – Jan 21, 2015 · Past) | Director · Since at least Nov 9, 2022 |
| Adam D. Levy Other companies: Mineralys Therapeutics, Inc. (Chief Financial Officer · Since at least Feb 9, 2023); Brickell Biotech Inc (Chief Business Officer · Aug 31, 2019 – Mar 16, 2020 · Past); Viridian Therapeutics, Inc. (Chief Business Officer · Feb 13, 2017 – Feb 6, 2019 · Past) | Chief Financial Officer · Since at least Apr 1, 2025 |
| Mansoor Raza Mirza Other companies: Sera Prognostics, Inc. (Director · Since at least Jul 14, 2021); Karyopharm Therapeutics Inc. (Director · Since at least Nov 5, 2013) | Chief Medical Officer · Since at least Apr 9, 2025 |
| Sharon Shacham Other companies: Nasus Pharma Ltd. (Board Member · Since at least Mar 18, 2026); Karyopharm Therapeutics Inc. (Chief Scientific Officer · Sep 16, 2019 – Mar 29, 2022 · Past) | Director · Since at least Nov 9, 2022 |
| Jean-Marie Cuillerot Other companies: Agenus Inc. (Chief Medical Officer · Jan 26, 2017 – Mar 31, 2017 · Past) | Chief Medical Officer · Jan 2, 2024 – Mar 1, 2025 · Past |
| Mary-Alice Miller Other companies: Butterfly Network, Inc. (General Counsel & Corp Sec · Feb 12, 2021 – Mar 22, 2022 · Past) | Chief Legal Officer · Since at least Sep 26, 2023 |
| Santhosh Palani Other companies: Pyxis Oncology, Inc. (Director · Since at least Mar 12, 2024) | Director · Since at least Mar 4, 2024 |
| Caroline Wigerup | Vice President, Research and Business Operations · Since at least Nov 4, 2026 |
| Eric Devroe | Chief Operating Officer · Since at least Nov 9, 2022 |
| Erick Gamelin | Chief Development Officer · Since at least Nov 9, 2022 |
| Katharine Peterson | Chief Accounting Officer · Since at least May 13, 2024 |
| Kristina Masson | Co-Founder, EVP, Business Operations, Site Head, Director · Since at least Nov 9, 2022 |
| Michaela Levin | Chief Business Officer · Since at least Aug 31, 2026 |
| Peter Blume-Jensen | Director · Since at least Nov 9, 2022 |
| Rasmus Holm-Jorgensen | Chief Financial Officer · Nov 9, 2022 – Mar 1, 2025 · Past |